A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 256 in Patients with Advanced Solid Tumors

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 62278
NMA SSA Reference Number: SSA/62278/MonH-2020-217799(v1)
Monash Health Reference: RES-20-0000-187A
Effective start/end date15/07/2014/07/25


  • clinical trial
  • treatment efficacy
  • treatment safety
  • solid tumours
  • Pharmacokinetics